Bringing a new vitrectomy device to market is a rigorous and expensive process. Because these devices are used inside the eye—a "closed" and highly sensitive environment—they are classified as Class II or Class III medical devices by regulatory bodies like the FDA in the United States or the EMA in Europe. This means they must undergo extensive clinical trials to prove both safety...